Biological Age in Worksite Health Promotion (BA1)

May 18, 2018 updated by: Jørn Wulff Helge, University of Copenhagen

Implementation of Biological Age in Worksite Health Promotion - a Cohort Study on >4000 Danish Employees and Their Health Risk Reductions

This cohort study investigates how implementation of Biological Age technology in worksite health promotion, affects health behavior in the general Danish working population.

Study Overview

Status

Completed

Detailed Description

This cohort study is designed on the basis of Body Age tests, executed by a private Danish health care company in the period from 2010 to 2013.

The dataset comprises pre- and post Body Age tests from >4000 individuals. They used a standardised protocol and educated staff ( physiotherapists or with a degree in sports science) to carry out the tests. Body Age tests apply biometrics, fitness level and health status data of the employee. The test results are characterized by a Body Age score, which defines the employee's biological age (in years).

This design categorises as a register study why The Danish National Committee is not applied for.

Study Type

Observational

Enrollment (Actual)

5473

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Copenhagen, Denmark, 2200
        • University of Copenhagen, Department of Biomedical Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The volunteers are employees in either private or governmental companies. A total of 18 different companies are included in this study, primarily related to banking, pension and pharmaceutical work areas. The Body Age test is voluntary and part of the companies health strategy and fringe benefits.

Description

Inclusion Criteria:

  • Males and females interested in their personal health status
  • Participants who perform both baseline and follow up test.

Exclusion Criteria:

  • Use of beta blockers

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Biological Age
Time Frame: The Biological Age is calculated at baseline and at one year follow up
An algorithm calculates Biological Age, using physiological parameters and biomarkers measured during the test.
The Biological Age is calculated at baseline and at one year follow up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
BMI
Time Frame: Measured at baseline and at one year follow up
BodyMassIndex is a major risk factor for developing lifestyle related diseases.
Measured at baseline and at one year follow up
Bodyweight
Time Frame: Measured at baseline and at one year follow up
The weight in kilograms of each individual
Measured at baseline and at one year follow up
FM
Time Frame: Measured at baseline and at one year follow up
Fat Mass is important to look at isolated in reference to whole bodyweight
Measured at baseline and at one year follow up
FFM
Time Frame: Measured at baseline and at one year follow up
Fat Free Mass is important to look at isolated in reference to Whole bodyweight
Measured at baseline and at one year follow up
BP
Time Frame: Measured at baseline and at one year follow up
Bloodpressure as a result from systolic and diastolic bloodpressure
Measured at baseline and at one year follow up
VO2max
Time Frame: Measured at baseline and at one year follow up
Maximal Oxygen consumption
Measured at baseline and at one year follow up
BG
Time Frame: Measured at baseline and at one year follow up
Blood Glucose
Measured at baseline and at one year follow up
HDL
Time Frame: Measured at baseline and at one year follow up
High Density Lipoprotein
Measured at baseline and at one year follow up
LDL
Time Frame: Measured at baseline and at one year follow up
Low Density Lipoprotein
Measured at baseline and at one year follow up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jørn W Helge, Prof., BMI, Xlab

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2007

Primary Completion (Actual)

June 1, 2013

Study Completion (Actual)

June 1, 2013

Study Registration Dates

First Submitted

May 7, 2018

First Submitted That Met QC Criteria

May 7, 2018

First Posted (Actual)

May 18, 2018

Study Record Updates

Last Update Posted (Actual)

May 22, 2018

Last Update Submitted That Met QC Criteria

May 18, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • BiologicalAge1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Health Behavior

3
Subscribe